EP3298007

ANHYDROUS CRYSTALLINE FORM OF (1S)-1,5-ANHYDRO-1-[3-[[5-(4-FLUOROPHENYL)-2-THIENYL]METHYL]-4-METHYLPHENYL]-D-GLUCITOL

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    18.5.2016
  • EP published:
    22.7.2020
  • EP application number:
    16730933.5
  • Max expiry date:
    17.5.2036
  • Title:
    ANHYDROUS CRYSTALLINE FORM OF (1S)-1,5-ANHYDRO-1-[3-[[5-(4-FLUOROPHENYL)-2-THIENYL]METHYL]-4-METHYLPHENYL]-D-GLUCITOL

Timeline

Today
18.5.2016EP application
22.7.2020EP Publication

Owner

  • Name:
    Janssen Pharmaceutica NV
  • Address:
    Turnhoutseweg 30, 2340 Beerse, BE

Inventor

  • Name:
    BRESLIN, David T.
  • Address:
    Spring House, Pennsylvania 19477, US
  • Name:
    FAWZY, Nagy E.
  • Address:
    Spring House, Pennsylvania 19477, US
  • Name:
    SCHAEFER, John
  • Address:
    Spinghouse, Pennsylvania 19477, US

Priority

  • Number:
    201562165265 P
  • Date:
    22.5.2015
  • Country:
    US

Classification

  • Categories:
    C07D 409/10, A61K 31/381, A61P 3/10

Upload documents